Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
Conditions:   Non-Alcoholic Fatty Liver Disease;   Type2diabetes Interventions:   Drug: Empagliflozin 10 MG;   Drug: Pioglitazone 15mg;   Drug: Metformin Sponsor:   Jinnah Postgraduate Medical Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials

The Neuroendocrine Effects of Pioglitazone in Patients With Lung Cancer and Cachexia
Condition:   Lung Cancer Interventions:   Drug: Pioglitazone 45 mg;   Drug: Placebo Sponsor:   Pennington Biomedical Research Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials